Press Releases

Date	Title	Company
05-Jan-2023	Biophytis announces its participation in two major investor conferences in January, in the United States and in France: the JP Morgan Healthcare Conference and the Invest Securities Biomed	Biophytis
05-Jan-2023	Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action	ABIVAX
05-Jan-2023	STEMart Introduces API Impurity Identification Services for Medical Devices	STEMart
05-Jan-2023	CD BioSciences Introduces Label-Free Live Cell Imaging Services for Bio-Research	CD BioSciences
05-Jan-2023	CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies	CD BioSciences
04-Jan-2023	SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation	SYNLAB AG
04-Jan-2023	SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB	SYNLAB AG
04-Jan-2023	Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation	Infex Therapeutics
04-Jan-2023	Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program	Hummingbird Bioscience
04-Jan-2023	Needle-Free Injectors Market exhibiting CAGR of 15.5% by 2032, owing to rise in demand for self-injection devices \| insightSLICE	insightSLICE
04-Jan-2023	Medical Scrubs Market is predicted to grow at a significant CAGR by 2032, owing to increase in the incidence of zoonotic diseases \| insightSLICE	insightSLICE
04-Jan-2023	High Potent Active Pharmaceutical Ingredients (HPAPI) Market is geared to grow at a CAGR of 9.1% by 2032 \| insightSLICE	insightSLICE
04-Jan-2023	Disposable Syringes Market to achieve CAGR of 6.1% by 2032 owing to increasing adoption of safety syringes \| insightSLICE	insightSLICE
04-Jan-2023	Diagnostic Enzymes Market is projected to accelerate at a CAGR of 6.3% by 2032, owing to rising demand for enzymes in diagnostics \| insightSLICE	insightSLICE
04-Jan-2023	Autotransfusion Devices Market to exhibit a CAGR of 5.2% by 2032, owing to rising number of transplant procedures \| insightSLICE	insightSLICE
04-Jan-2023	ISA Pharmaceuticals and Cancer Focus Fund Announce $5 Million Investment to Support First-in-Human Trial of ISA’s Novel Immunotherapy ISA103 in Uveal Melanoma	ISA Pharmaceuticals
04-Jan-2023	Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers	Biognosys and Bruker
04-Jan-2023	Tiziana Life Sciences Announces IND filed for Phase 2 Study of Milciclib in Combination with Gemcitabine for Non-Small Cell Lung Cancer	Tiziana Life Sciences
04-Jan-2023	Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
04-Jan-2023	Calibre Scientific Acquires TechniVal Group, a Comprehensive Provider of Laboratory Equipment Services in the United Kingdom	Calibre Scientific